A new stroke thrombolytic — tenecteplase — marketed as TNKase — has received FDA approval, marking the first such advancement in nearly 30 years. Unlike alteplase (tPA), which requires a lengthy ...

Objective: To reanalyze data from two previous studies to provide stronger evidence of benefit for early use of single-dose intravenous bolus salbutamol in children with acute severe exacerbations ...

The 5-second intravenous bolus offers faster, simpler administration than Activase. (HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

So overall, I think very excited about the intravenous LEQEMBI approval that ... But importantly, there is going to be this bolus of patients who are going to be completing their 18-month therapy ...

Enable Injections announced today that it received CE mark approval for its EnFuse syringe transfer system for drug delivery.

A review of the available randomised control trials suggests that a bolus of intravenous salbutamol may reduce symptoms and hasten recovery. Aminophylline infusions may improve lung function, and in ...

After infusion of the intravenous bolus doses or subcutaneous injections of test agents, fasting antroduodenal manometry and EGG recordings were continued for another 30 minutes. Each subject then ...

SCRANTON — A Lackawanna County Court judge on Thursday excluded Bob Bolus as a candidate for Scranton mayor in the May 20 Republican primary. In an unrelated ballot challenge, a different judge ...